top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Current Insights on Lipid-Based Nanosystems
Current Insights on Lipid-Based Nanosystems
Autore Silva Ana Catarina
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (368 p.)
Soggetto topico Technology: general issues
Soggetto non controllato Echinococcus granulosus
scolicidal
nanoliposome
juglone
apoptotic activity
hydrogel
SLNs
nose-to-brain delivery
mucoadhesion
quality by design
antioxidant activity
nasal administration
nanostructured lipid carriers
solid lipid nanoparticles
in vitro cell cultures
3D nasal casts
lung cancer
targeted drug delivery
lipid-based nanocarriers
pulmonary delivery
dry powder inhalers
aerosols
liposomes
nanoemulsions
nanotechnology
biologically active compounds
dermal drug delivery
polyphenols
phytophenols
skin permeation
chemotherapy
radiotherapy
active targeting
passive targeting
tumor
immunoconjugate
traditional liposome
stealth liposome
triggered release
limitations of liposomes
drug transfer
in vitro release
colloidal drug carriers
lipid nanoparticles
hydrogel beads
cholesteryl nonanoate
bovine serum albumin
skin diseases
lipid-based nanosystems
cream
ointment
gel
pH-sensitive
liposome
imidazole
anticancer
drug delivery
multicellular spheroids
dapagliflozin
Box-Behnken design
FTIR
DSC
XRD
SEM
AFM
in vitro Franz diffusion cells
lipid-based nanoparticles
nanocarrier
surface charge
delivery systems
chronic treatment
mice
anti-oxidant activity
hepatoprotective effect
phospholipid
phytosomes
Silymarin
Colorectal Cancer
Niosomes
Oxaliplatin
Paclitaxel
d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS)
therapeutic nucleic acids
schizophrenia
quetiapine fumarate
glycerosomes
central composite rotatable design
bioavailability
pharmacokinetic
ISBN 3-0365-6165-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910639995103321
Silva Ana Catarina  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug metabolism, pharmacokinetics and bioanalysis / / special issue editors, Hye Suk Lee, Kwang-Hyeon Liu
Drug metabolism, pharmacokinetics and bioanalysis / / special issue editors, Hye Suk Lee, Kwang-Hyeon Liu
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (230 p.)
Disciplina 615.1
Soggetto topico Drugs - Metabolism
Soggetto non controllato human liver microsomes
alcohol addiction
UGT
ultra-high-pressure liquid chromatography
adalimumab
procainamide
LC-MS/MS
DA-9805
paeonol
LC-QTOF-MS/MS
YRA-1909
chlorogenic acid
immunoprecipitation
Eurycoma longifolia
CYP
caffeic acid
rat
pharmaceutical excipient
Korean red ginseng extract
Stauntonia hexaphylla leaf extract
bioanalysis
HPLC-MS/MS
B6
eurycomanone
bioavailability
drying technology
GB3
diclofenac
129-Glatm1Kul/J
aglycone
caffeic acid O-glucuronides
organic anion transporting polypeptide
protein precipitation
metabolic stability
Fabry disease
biopharmaceuticals
imperatorin
neochlorogenic acid
gastric ulcer
saikosaponin a
hair
anthraquinone
acetyl tributyl citrate
pharmacokinetics
brain distribution
mematine
ethyl glucuronide
pharmacokinetic
loxoprofen
liquid chromatography-quadrupole TOF MS
glucuronidation
esomeprazole
metformin
cytochrome P450
glycoside
AUDIT score
protein stability
efficacy
LC-HR/MS
cryptochlorogenic acid
aceclofenac
drug interaction
liquid chromatography-tandem mass spectrometry
Osthenol
plasma
N-acetylprocainamide
diabetes
ISBN 3-03897-917-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346664803321
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Lignans
Lignans
Autore Barker David
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (384 p.)
Soggetto non controllato taste-active compound
heilaohu
9-norlignans
antioxidant activity
drug-like
human health
chemometrics
lignan
bitterness
red-flowered Chinese magnolia vine
antioxidant
ruminant
secoisolariciresinol diglucoside
quantification
intermolecular interactions
cattle
anti-inflammatory activity
acyl-Claisen
LOX
seed
food groups
microtubules
anti-proliferative
acetylcholinesterase inhibitors
flax
arylnaphthalene lignan
epiboly
aryldihydronaphthalene lignan
multiple bioactive components
enterolignan
total synthesis
genetic
synthesis
cultivated
cell cycle
chronic diseases
national databases
oxidation
chemical components
molecular dynamics
COX
lignans
hydroxycinnamic acid
chemical structures
Chinese magnolia vine
stereoselective synthesis
sPLA2
Bursera fagaroides
in silico studies
antibacterial activity
semisynthesis
dibenzyl butyrolactones
flavonoid glycoside
lignan glycoside
chemical characterization
hydroxymatairesinol
podophyllotoxin
Lespedeza cuneata
Bursera
oak ageing
Schisandrae Chinensis Fructus
F-actin
cultivar
UHPLC-MS/MS
bioactivity
podophyllotoxin-type lignans
harmonized databases
graph theory
antioxidants
health promotion
simultaneous quantitation
natural products
dietary intake
cell migration
Lignan
chemical space
diet
Lauraceae
pharmacokinetic
cytotoxicity
tujia ethnomedicine
flavonolignans
flavonol
adipocyte and osteoblast differentiation
Burseraceae
environment
dietary lignans
phytochemical analysis
Schisandra chinensis
animal health
neolignans
Schisandra rubriflora
cancer
norlignans
wild
ISBN 3-03897-909-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346692503321
Barker David  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Polymeric Carriers for Biomedical and Nanomedicine Application
Polymeric Carriers for Biomedical and Nanomedicine Application
Autore Lima Sofia
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (186 p.)
Soggetto topico Technology: general issues
Soggetto non controllato osteoarthritis
monosodium iodoacetate
p47phox
PLGA nanoparticles
reactive oxygen species
full factorial design
optimization
metronidazole
nanocomposites
sodium alginate
chitosan
PLGA
hybrid polymers
chitosan-PLGA polymer
NMR
DSC
FT-IR
covalent drug conjugation
therapeutic nanodevice
polymeric nanoparticles
cancer therapy
controlled drug delivery
redox responsive PEG-block-PLA
nanocarriers
disulfide bond
controlled release
retinol
nanosponge
hydrogel
Box-Behnken design
pharmacokinetic
terbinafine hydrogel
niacinamide
polyethene glycol (PEG) 400
solvent
dermal delivery
finite dose
porcine skin
dissolving microneedles
multiple sclerosis
PLP
transdermal delivery
tyrosol
nanoparticles
Design of Experiment (DoE)
β cyclodextrin
DNA binding
glyconanoparticles
immunotherapy
infectious diseases
mannose receptors
nutraceuticals
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557739303321
Lima Sofia  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recent Advances and Clinical Outcomes of Kidney Transplantation : Volume 2
Recent Advances and Clinical Outcomes of Kidney Transplantation : Volume 2
Autore Cheungpasitporn Wisit
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (270 p.)
Soggetto topico Medicine
Soggetto non controllato malondialdehyde
oxidative stress
new-onset diabetes
renal transplantation
BK virus
BK virus nephropathy
kidney allograft
transplantation
Alport syndrome
children
autosomal dominant polycystic kidney disease
epidemiology
hospitalization
kidney transplantation
subarachnoid hemorrhage
malignancy
post-transplant malignancy
renal cell carcinoma
meta-analysis
systematic reviews
tacrolimus
C/D-ratio
pharmacokinetics
opportunistic infection
allograft survival
urological complications
ureteric stent
urinary tract infection
timing of removal
living donor
ethnicity
age
obesity
genetic relationship donor/recipient
atypical hemolytic uremic syndrome
eculizumab
glucose intolerance
insulin secretion
insulin resistance
oral glucose tolerance test
healthy subject
hyperchloremia
kidney graft dysfunction
living donor kidney transplantation
Uropathogenic E. coli
UPEC
phylogeny
genomics
antibiotic resistance
virulence traits
night-time renal transplantation
graft survival
patient survival/outcome
surgical complications
acute rejection
lymphocyte
CD45RC
Belatacept
cardiovascular high risk
outcome
machine perfusion
organ preservation
temperature
hypothermic
normothermic
transplant
proton-pump inhibitors
iron
iron deficiency
polyomavirus
BKV
kidney
glomerulus
BKVAN
nephropathy
fluid management
delayed graft function
goal-directed fluid therapy
calcineurin inhibitor nephrotoxcity
C/D ratio
tacrolimus metabolism
ADPKD
native nephrectomy
patient outcome
perioperative complications
epidermal growth factor
creatinine
graft failure
new onset diabetes after renal transplantation
single nucleotide polymorphisms
urinary biomarkers
α-GST
π-GST
nephrotoxicity
urinary excretion of N1-methylnicotinamide
mortality
niacin status
dietary intake
tryptophan
vitamin B3
Kidney transplant
vitamin C
cancer mortality
mycophenolic acid
immunosuppression
plasmapheresis
oxalate
hyperoxaluria
kidney transplant recipients
post-transplantation diabetes mellitus
all-cause mortality
cardiovascular mortality
infectious mortality
magnesium
hypomagnesaemia
cancer
kidney transplant
survival
living kidney donation
living-donor kidney transplantation
beliefs
inequity
ischemia reperfusion injury
innate immune system
adaptive immune system
apoptosis
necrosis
hypoxic inducible factor
endothelial dysfunction
proton pump inhibitor
transplant rejection
GFR
insulin-like growth factor 1
growth hormone
muscle mass
patient survival
physical activity
renal transplant recipients
kidney transplant (KT)
donor-specific antibodies (DSA)
C3d-binding assay
antibody-mediated rejection (AMR)
arsenic
diet
fish consumption
post-transplant diabetes mellitus
N1-methyl-2-pyridone-5-carboxamide
N1-methylnicotinamide
urinary excretion
kidney function
biomarker
branched chain amino acids
posttransplant diarrhea
methanogenesis
Methanosphaera stadtmanae
mucins
sulfate-reducing bacteria
acute humoral rejection
first-line therapy
outcomes
proteasome inhibitor
renal transplant
transplant recipients
calcineurin inhibitors
FK506
pharmacokinetic
fast tacrolimus metabolizers
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Recent Advances and Clinical Outcomes of Kidney Transplantation
Record Nr. UNINA-9910557787303321
Cheungpasitporn Wisit  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recent Advances and Clinical Outcomes of Kidney Transplantation
Recent Advances and Clinical Outcomes of Kidney Transplantation
Autore Cheungpasitporn Wisit
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (342 p.)
Soggetto topico Medicine
Soggetto non controllato malondialdehyde
oxidative stress
new-onset diabetes
renal transplantation
BK virus
BK virus nephropathy
kidney allograft
transplantation
Alport syndrome
children
autosomal dominant polycystic kidney disease
epidemiology
hospitalization
kidney transplantation
subarachnoid hemorrhage
malignancy
post-transplant malignancy
renal cell carcinoma
meta-analysis
systematic reviews
tacrolimus
C/D-ratio
pharmacokinetics
opportunistic infection
allograft survival
urological complications
ureteric stent
urinary tract infection
timing of removal
living donor
ethnicity
age
obesity
genetic relationship donor/recipient
atypical hemolytic uremic syndrome
eculizumab
glucose intolerance
insulin secretion
insulin resistance
oral glucose tolerance test
healthy subject
hyperchloremia
kidney graft dysfunction
living donor kidney transplantation
Uropathogenic E. coli
UPEC
phylogeny
genomics
antibiotic resistance
virulence traits
night-time renal transplantation
graft survival
patient survival/outcome
surgical complications
acute rejection
lymphocyte
CD45RC
Belatacept
cardiovascular high risk
outcome
machine perfusion
organ preservation
temperature
hypothermic
normothermic
transplant
proton-pump inhibitors
iron
iron deficiency
polyomavirus
BKV
kidney
glomerulus
BKVAN
nephropathy
fluid management
delayed graft function
goal-directed fluid therapy
calcineurin inhibitor nephrotoxcity
C/D ratio
tacrolimus metabolism
ADPKD
native nephrectomy
patient outcome
perioperative complications
epidermal growth factor
creatinine
graft failure
new onset diabetes after renal transplantation
single nucleotide polymorphisms
urinary biomarkers
α-GST
π-GST
nephrotoxicity
urinary excretion of N1-methylnicotinamide
mortality
niacin status
dietary intake
tryptophan
vitamin B3
Kidney transplant
vitamin C
cancer mortality
mycophenolic acid
immunosuppression
plasmapheresis
oxalate
hyperoxaluria
kidney transplant recipients
post-transplantation diabetes mellitus
all-cause mortality
cardiovascular mortality
infectious mortality
magnesium
hypomagnesaemia
cancer
kidney transplant
survival
living kidney donation
living-donor kidney transplantation
beliefs
inequity
ischemia reperfusion injury
innate immune system
adaptive immune system
apoptosis
necrosis
hypoxic inducible factor
endothelial dysfunction
proton pump inhibitor
transplant rejection
GFR
insulin-like growth factor 1
growth hormone
muscle mass
patient survival
physical activity
renal transplant recipients
kidney transplant (KT)
donor-specific antibodies (DSA)
C3d-binding assay
antibody-mediated rejection (AMR)
arsenic
diet
fish consumption
post-transplant diabetes mellitus
N1-methyl-2-pyridone-5-carboxamide
N1-methylnicotinamide
urinary excretion
kidney function
biomarker
branched chain amino acids
posttransplant diarrhea
methanogenesis
Methanosphaera stadtmanae
mucins
sulfate-reducing bacteria
acute humoral rejection
first-line therapy
outcomes
proteasome inhibitor
renal transplant
transplant recipients
calcineurin inhibitors
FK506
pharmacokinetic
fast tacrolimus metabolizers
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557632603321
Cheungpasitporn Wisit  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui